<- Go Home
Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Market Cap
$8.5B
Volume
1.7M
Cash and Equivalents
$156.0M
EBITDA
$1.0B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$4.1B
Profit Margin
31.14%
52 Week High
$89.29
52 Week Low
$60.56
Dividend
N/A
Price / Book Value
2.64
Price / Earnings
22.61
Price / Tangible Book Value
-4.08
Enterprise Value
$13.3B
Enterprise Value / EBITDA
11.58
Operating Income
$742.0M
Return on Equity
8.70%
Return on Assets
4.33
Cash and Short Term Investments
$156.0M
Debt
$3.4B
Equity
$4.8B
Revenue
$13.2B
Unlevered FCF
$476.8M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium